Immunome, Inc GAAP EPS of -$0.78 misses by $0.21

Immunome, Inc press release ( NASDAQ: IMNM ): Q3 GAAP EPS of -$0.78 misses by $0.21 .

Immunome reported a net loss of $47.1 million for the quarter ended September 30, 2024. More on Immunome, Inc Seeking Alpha’s Quant Rating on Immunome, Inc Historical earnings data for Immunome, Inc Financial information for Immunome, Inc.